logo

COGT

Cogent Biosciences·NASDAQ
--
--(--)
--
--(--)
6.40 / 10
Outperform

Analyst sentiment is bullish with H.C. Wainwright lifting its target to $52 and Wedbush also rating the stock positively. Fund-flow data show consistent inflows across all sizes (extra-large inflow ratio 0.53), supporting the bullish view. However, the current price decline (-7.78%) creates a mismatch with expectations. Together, analyst conviction and positive capital movement offset short-term technical weakness, pointing to potential recovery if momentum turns.

FundamentalSentiment(6.4)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

50%

Buy

50%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-21
InstitutionWedbush
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of COGT?
  • COGT holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.40/10 (Outperform).